An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: CDER Offices and Divisions

Office of Specialty Medicine (OSM)

The Office of Specialty Medicine (OSM) consists of two review divisions: The Division of Imaging and Radiation Medicine (DIRM) and the Division of Ophthalmology (DO). The Immediate office oversees the development, review, and regulation of applications for drug and biologic products reviewed in these divisions.

Director: Charles Ganley, M.D. (Acting)
Deputy Director: Alex Gorovets, M.D. (Acting)

Regulatory Operations
Director of Project Management Staff: Judit Milstein (Acting)

Contact Us

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation Research
Office of Specialty Medicine (OSM)
10903 New Hampshire Avenue WO22 Stop 5411
Silver Spring, MD 20993

Top